Related Experiment Video
Updated: Jan 12, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.9K
Machine learning analysis of posturography in panic disorder: a pilot study for objective physiological biomarker
Luiz Antonio Vesco Gaiotto1, Felipe O Aguiar1,2, Thales Marcon1
1Mental Health Department, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.
Frontiers in Psychiatry
|November 3, 2025
Summary
Machine learning analysis of stabilometric data effectively differentiates panic disorder (PD) patients from healthy individuals. This approach enhances the detection of subtle postural control abnormalities linked to PD.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Clinical Psychology
Background:
- Panic disorder (PD) is associated with subtle postural control deficits.
- Traditional statistical methods inadequately capture these abnormalities.
- Machine learning (ML) offers potential for enhanced detection of PD-related postural patterns.
Purpose of the Study:
- To evaluate static postural control in PD patients.
- To determine if ML analysis of stabilometric data can improve differentiation from healthy controls.
Main Methods:
- A cross-sectional case-control study involving 12 PD patients and 21 healthy volunteers.
- Stabilometry was performed under five sensory conditions.
- ML models (Logistic Regression, Linear Discriminant Analysis, etc.) were trained and validated using stratified, subject-grouped cross-validation.
Main Results:
- Logistic Regression achieved 93.8% accuracy and an AUC of 96% in differentiating groups.
- Linear Discriminant Analysis showed the highest specificity (91.7%).
- PD patients exhibited significantly reduced mediolateral sway compared to controls.
Conclusions:
- ML applied to posturography can identify physiological markers for panic disorder.
- ML analysis of stabilometric data improves classification accuracy over traditional methods.
- Static posturography with ML may be superior to current clinical screening tools for PD.

